Abstract
We examined the characteristics of binding of radiolabeled N,N-dipropyl-2-[4-methoxy-3-(2-phenylethoxy)phenyl]-ethylamine monohydrochloride ([3H] NE-100), a highly potent and selective sigma-receptor ligand, to guinea-pig brain membranes. [3H]NE-100 showed saturable and reversible binding to sigma binding sites. A dissociation constant (Kd) and maximal numbers of binding sites (B max) obtained from Scatchard plot analysis were 1.2 ± 0.1 nM and 1049.3 ± 115.1 fmol/mg protein (n = 3), respectively. NE-100 was the most potent inhibitor of [3H]NE-100 binding among several structurally dissimilar sigma-receptor ligands, including haloperidol and ( + )-pentazocine. ( + )-Benzomorphanes had more than a 10-fold potent inhibitory activity over (−)-benzomorphanes, with regard to [3H]NE-100 binding. The binding of [3H]NE-100 was not influenced by histaminergic, dopaminergic, adrenergic, serotonergic cholinergic or glutaminergic agents at 10−7 M. GTP-γ-S and phenytoin also did not affect the binding of [3H]NE-100. A higher [3H]NE-100 binding was observed in the cerbellum and medulla oblongata. Except for the nuclear fraction, the highest level of [3H]NE-100 binding to subcellular fractions was observed in microsomal fractions. These results suggest that NE-100 selectively binds, with a high affinity, to sigma-1 binding sites in guinea-pig brain membranes, as an “antagonist”.
Similar content being viewed by others
References
Bylund DB, Snyder SH (1976) Beta-adrenergic receptor binding in membrane preparations from mammalian brain. Mol Pharmacol 12:568–580
Chaki S, Tanaka M, Muramatsu M, Otomo S (1994) NE-100, a novel potent σ ligand, preferentially binds to σ1 binding sites in guinea pig brain. Eur J Pharmacol 251:R1-R2
Cheng YC, Prusoff WH (1973) Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 percent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol 22:3099–3108
Craviso GL, Musacchio JM (1983a) High-affinity dextromethorphan binding sites in guinea pig brain. I. Initial characterization. Mol Pharmacol 23:619–628
Craviso GL, Musacchio JM (1983b) High-affinity dextromethorphan binding sites in guinea pig brain. II. Competition experiments. Mol Pharmacol 23:629–640
Culp SG, Rominger D, Tam WS, De Souza E (1992) [3H]DuP734 (1-cyclopropylmethyl]-4-(2′-(4″-fluorophenyl)-2′-oxoethyl)-piperidine HBr): a receptor binding profile of a high-affinity novel sigma receptor ligand in guinea pig brain. J Pharmacol Exp Ther 263:1175–1187
De Costa BR, Bowen WD, Hellewell SB, Walker JM, Thurkauf A, Jacobson AE, Rice KC (1989) Synthesis and evaluation of optically pure [3H]-(+)-pentazocine, a highly potent and selective radioligand for σ receptors. FEBS Lett 251:53–58
Gray NM, Contreras PC, Allen SE, Taylor DP (1990) H1 antihistamines interact with central sigma receptors. Life Sci 47:175–180
Gundlach AL, Largent BL, Snyder SH (1985) Phencyclidine and σ opiate receptors in brain: biochemical and autoradiographic differentiation. Eur J Pharmacol 113:465–466
Gundlach AL, Largent BL, Snyder SH (1986) Autoradiographic localization of σ-receptor binding sites in guinea pig and rat central nervous system with (+)-3H-3-(3-hydroxyphenyl)-N-(1-propyl)piperidine. J Neurosci 6:1757–1770
Itzhak Y (1988) Pharmacological specificity of some psychotomimetic and antipsychotic agents for the sigma and PCP binding sites. Life Sci 42:745–752
Itzhak Y (1989) Multiple affinity binding sites of the σ receptor: effect of GTP-binding protein-modifying agents. Mol Pharmacol 36:512–517
Karbon EW, Naper K, Pontecorvo MJ (1991) [3H]DTG and [3H]( + )-3-PPP label pharmacologically distinct σ binding sites in guinea pig brain membranes. Eur J Pharmacol 193:21–27
Katz JL, Spealman RD, Clark RD (1985) Stereoselective behavioral effects of N-allylnormetazocine in pigeons and squirrel monkeys. J Pharmacol Exp Ther 232:452–461
Knight AR, Nobel A, Wong EHF, Middlemiss DN (1991) The subcellular distribution and pharmacology of the sigma recognition site in guinea-pig brain and liver. Mol Neuropharmacol 1:71–75
Largent BL, Gundlach Al, Snyder SH (1984) Psychotomimetic opiate receptors labeled and visualized with (+)-[3H]3-(3-hydroxyphenyl)-N-(1-propyl)piperidine. Proc Natl Acad Sci USA 81:4983–4987
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275
Manallack DT, Wong MG, Costa M, Andrews PR, Beart PM (1988) Receptor site topographies for phencyclidine-like and σ drugs: predictions from quantitative conformational, electrostatic potential, and radioreceptor analysis. Mol Pharmacol 34:863–879
Martin WR, Eades CG, Thompson JA, Huppler RE, Gilbert PE (1976) The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog. J Pharmacol Exp Ther 197:517–532
McCann DJ, Rabin RA, Rens-Domiano S, Winter JC (1989) Phencyclidine/SKF-10,047 binding sites: evaluation of function. Pharmacol Biochem Behav 32:87–94
McCann DJ, Su TP (1990) Haloperidol sensitive [3H](+)-SKF10,047 binding sites (σ sites) exhibit a unique distribution in rat subcellular fractions. Eur J Pharmacol 188:211–218
McLean S, Weber E (1988) Autoradiographic visualization of haloperidol-sensitive sigma receptors in guinea-pig brain. Neuroscience 25:259–269
Mendelsohn LG, Kalra V, Johnson BG, Kerchner GA (1985) Sigma opioid receptor; characterization and co-identity with the phencyclidine receptor. J Pharmacol Exp Ther 233:597–602
Musacchio JM, Klein M, Santiago LJ (1987) Allosteric modulation of dextromethorphan binding sites. Neuropharmacology 26:997–1001
Okuyama S, Imagawa Y. Ogawa S, Araki H, Ajima A, Tanaka M, Muramatsu M, Nakazato A, Yamaguchi K, Yoshida M, Otomo S (1993) NE-100, a novel sigma receptor ligand: in vivo tests. Life Sci 53:PL285-PL290
Quirion R, Chicheportich R, Contreras PC, Johnson KM, Lodge D, Tam SW, Woods JH, Zukin SR (1987) Classification and nomenclature of phencyclidine and sigma receptor sites. Trends Neurosci 10:444–446
Quirion R, Bowen WD, Itzhak Y, Junien JL, Musacchio JM, Rothman RB, Su TP, Tam SW, Taylor DP (1992) A proporsal for the classification of sigma binding sites. Trends Pharmacol Sci 13:85–86
Ross SB (1991) Heterogeneous binding of sigma radioligands in the rat brain and liver: possible relationship to subforms of cytochrome P-450. Pharmacol Toxicol 68:293–301
Su TP (1982) Evidence for sigma opioid receptor: binding of [3H]SKF-10047 to morphine-inaccessible sites in guinea-pig brain. J Pharmacol Exp Ther 223:284–290
Tam SW (1983) Naloxone-inaccessible sigma receptor in rat central nervous system. Proc Natl Acad Sci USA 80:6703–6707
Tam SW, Cook L (1984) σ-Opiates and certain antipsychotic drugs mutually inhibit (+)-[3H]SKF10,047 and [3H]haloperidol binding in guinea pig brain membranes. Proc Natl Acad Sci USA 81:5618–5621
Tanaka M, Chaki S, Imagawa Y, Okuyama S, Muramatsu M, Otomo S (1993a) FH-510, a potent and selective ligand for rat brain a recognition sites. Eur J Pharmacol 238:89–92
Tanaka M, Kaku S, Muramatsu M, Otomo S (1993b) Binding of [3H]FH-510 to σ ligand recognition sites in guinea-pig brain membranes. Eur J Pharmacol 238:93–100
Vaupel DB (1983) Naltrexone fails to antagonize the a effects of PCP and SKF10,047 in the dog. Eur J Pharmacol 92:269–274
Walker JM, Bowen WD, Matsumoto RR, De Costa B, Rice KC (1990) Sigma receptors: biology and function. Pharmacol Rev 42:355–402
Weber E, Sonders M, Quarum M, McLean S, Pon S, Keana JF (1986) 1,3-Di(2-[5-3H]tolyl)guanidine: a selective ligand that labels sigma-type receptors for psychotomimetic opiates and antipsychotic drugs. Proc Natl Acad Sci USA 83: 8784–8788
Zhou G-Z, Musacchio JM (1991) Computer-assisted modeling of multiple dextromethorphane and sigma binding sites in guinea pig brain. Eur J Pharmacol 206:261–269
Zukin SR, Brady KT, Slifer BL, Balster RL (1984) Behavioral and biochemical stereoselectivity of sigma opiate/PCP receptors. Brain Res 294:174–177
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tanaka, M., Shirasaki, T., Kaku, S. et al. Characteristics of binding of [3H]NE-100, a novel sigma-receptor ligand, to guinea-pig brain membranes. Naunyn-Schmiedeberg's Arch Pharmacol 351, 244–251 (1995). https://doi.org/10.1007/BF00233243
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00233243